Although 95% CIs always overlapped, a slightly lower proportion of anti-HCV+ than anti-HCV− NHL cases had less than 50 CD4+ cells μl−1 at cancer diagnosis (26.0 vs 35.9%, respectively), or were diagnosed with PBL (19.0 vs 25.8%, respectively). This evidence concerns the gene CD4 and non-Hodgkin lymphoma.